MedPath

Ibuprofen

Ibuprofen Tablets, USP (400 mg, 600 mg and 800 mg) Rx Only

Approved
Approval ID

faebc392-0fd9-4c71-8471-beba10dda022

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 31, 2023

Manufacturers
FDA

Amneal Pharmaceuticals of New York LLC

DUNS: 123797875

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ibuprofen

PRODUCT DETAILS

NDC Product Code53746-464
Application NumberANDA078558
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 31, 2023
Generic NameIbuprofen

INGREDIENTS (1)

IBUPROFENActive
Quantity: 400 mg in 1 1
Code: WK2XYI10QM
Classification: ACTIB

Ibuprofen

PRODUCT DETAILS

NDC Product Code53746-466
Application NumberANDA078558
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 31, 2023
Generic NameIbuprofen

INGREDIENTS (1)

IBUPROFENActive
Quantity: 800 mg in 1 1
Code: WK2XYI10QM
Classification: ACTIB

Ibuprofen

PRODUCT DETAILS

NDC Product Code53746-465
Application NumberANDA078558
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 31, 2023
Generic NameIbuprofen

INGREDIENTS (1)

IBUPROFENActive
Quantity: 600 mg in 1 1
Code: WK2XYI10QM
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ibuprofen - FDA Drug Approval Details